Coherus Oncology Inc (CHRS)

Sales/Maturities of Investments

$81.67M

Quarterly · Period ending: · USD

CHRS logo

CHRS Sales/Maturities of Investments

Latest reported$81.67M
CHRS Quarterly Sales/Maturities of Investments ($0.00 → $81.67M)
High-resolution chart · PNG

CHRS sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
81,671,000
38,135,000
19,812,000
1,650,000
0
0
0
0
0
14,888,000
36,212,000
43,398,000
60,532,000
17,500,000
0
0
0
0
118,664,000
47,700,000
0
0
0
63,000,000
0
0
5,400,000
6,000,000
0
0
16,000,000
14,000,000
0
0
14,500,000
45,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.